HC Wainwright & Co. Reiterates Buy on Molecular Partners, Maintains $13 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.7%

Neg 0% Neu 89.7% Pos 0%

HC Wainwright & Co. analyst Robert Burns reiterates Molecular Partners (NASDAQ:MOLN) with a Buy and maintains $13 price target.